The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Abstract
BACKGROUND: Conflicting reports have caused controversy on whether cysticidal drugs modify the natural course of neurocysticercosis. PURPOSE: To perform a meta-analysis of randomized trials assessing the effect of cysticidal drugs on neuroimaging and clinical outcomes of patients with neurocysticercosis. DATA SOURCES: Search of MEDLINE, Cochrane Database of Systematic Reviews, and Literatura Latino-Americana y del Caribe en Ciencias de la Salud (LILACS) between 1979 and 2005. There were no language restrictions. STUDY SELECTION: Randomized trials of cysticidal drug therapy for neurocysticercosis that met predefined criteria designed to allow characterization of the disease and objective evaluation of therapy. The authors independently reviewed articles. Abstracted data included study design, number of randomly assigned patients and withdrawals, intervention, adverse events, timing of neuroimaging studies, and outcomes. DATA SYNTHESIS: Eleven studies met the inclusion criteria. Six trials randomly assigned 464 patients with cystic lesions (vesicular cysticerci), and 5 trials randomly assigned 478 patients with enhancing lesions (colloidal cysticerci). Parasites were located in the brain parenchyma or subarachnoid space at the convexity of the cerebral hemispheres. Cysticidal drug therapy was associated with complete resolution of cystic lesions (44% vs. 19%; P = 0.025). Trials on enhancing lesions showed a trend toward lesion resolution favoring the use of cysticidal drugs (72% vs. 63%; P = 0.38) that became statistically significant when an outlier trial was excluded from the analysis (69% vs. 55%; P = 0.006). Risk for seizure recurrence was lower after cysticidal treatment in patients with enhancing lesions (14% vs. 37%; P < 0.001). The single trial evaluating the frequency of seizures in patients with cystic lesions showed a 67% reduction in the rate of generalized seizures with treatment (P = 0.006). LIMITATIONS: Not all studies focused on the control of seizures as an outcome. CONCLUSIONS: Cysticidal drug therapy results in better resolution of colloidal and vesicular cysticerci, lower risk for recurrence of seizures in patients with colloidal cysticerci, and a reduction in the rate of generalized seizures in patients with vesicular cysticerci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
J. Sweeting, M., J. Sutton, A., & C. Lambert, P. (2004) · Statistics in Medicine · doi:10.1002/sim.1761 · Cited by 1,734 · cited 1×
“For studies that involved outcomes with zero cell frequencies in 1 of the 2 groups, we used a “treatment arm” continuity correction, which adds a factor of the reciprocal of the size of the opposite treatment arm to the cells (9).”
MethodAlbendazole Therapy for Neurocysticercosis
Escobedo, F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370040120021 · Cited by 170
Neurocysticercosis: Short Course of Treatment With Albendazole
Alarcón, F. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520470099034 · Cited by 63 · cited 4×
“Some patients had a transient exacerbation of seizures during the trial, and a few developed signs of increased intracranial pressure (15, 17, 20, 22, 23).”
BackgroundResultInfluential
Cited by
Clinical symptoms, diagnosis, and treatment of neurocysticercosis
Garcia, H. H., Nash, T. E., & Del Brutto, O. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70094-8 · Cited by 594
Self-citationBacterial, Fungal, Parasitic, and Viral Myositis
Crum-Cianflone, N. F. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-08 · Cited by 422
White, A. C., Coyle, C. M., Rajshekhar, V., Singh, G., Hauser, W. A., Mohanty, A., Garcia, H. H., & Nash, T. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1084 · Cited by 285
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., Pretell, E. J., Bonato, P. S., Lanchote, V. L., Takayanagui, O. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz085 · Cited by 19
Metadata
- Authors
- Del Brutto, O. H., Roos, K. L., Coffey, C. S., & García, H. H.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-07-04
- Volume
- 145
- Issue
- 1
- Pages
- 43-51
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1597938189
- Cited by
- 231
- References
- 3
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel. https://app.cochat.ai/papers/10.7326/0003-4819-145-1-200607040-00009
- The paper
- Del Brutto, O. H., Roos, K. L., Coffey, C. S., & García, H. H. (2006). Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-145-1-200607040-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.